CXCL12 and neoplasm: In the CD8-negative cohort, the combined high expression of CXCR4 and its ligand SDF-1 was associated with decreased overall survival, suggesting that the detrimental effect of CXCR4/SDF-1 depends on the density of tumor infiltrating CD8-positive T lymphocytes.